Direct Activation of Human MLKL by a Select Repertoire of Inositol Phosphate Metabolites
Dan E McNamara1, Cole M Dovey2, Andrew T Hale3
1Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Abstract:
Necroptosis is an inflammatory form of programmed cell death executed through plasma membrane rupture by the pseudokinase mixed lineage kinase domain-like (MLKL). We previously showed that MLKL activation requires metabolites of the inositol phosphate (IP) pathway. Here we reveal that I(1,3,4,6)P4, I(1,3,4,5,6)P5, and IP6 promote membrane permeabilization by MLKL through directly binding the N-terminal executioner domain (NED) and dissociating its auto-inhibitory region. We show that IP6 and inositol pentakisphosphate 2-kinase (IPPK) are required for necroptosis as IPPK deletion ablated IP6 production and inhibited necroptosis. The NED auto-inhibitory region is more extensive than originally described and single amino acid substitutions along this region induce spontaneous necroptosis by MLKL. Activating IPs bind three sites with affinity of 100-600 μM to destabilize contacts between the auto-inhibitory region and NED, thereby promoting MLKL activation. We therefore uncover MLKL's activating switch in NED triggered by a select repertoire of IP metabolites.
Insights
Inositol phosphates (IPs) activate mixed lineage kinase domain-like (MLKL) to trigger programmed cell death (necroptosis). Specific IPs bind MLKL
Area of Science:
- Molecular Biology
- Cell Death Research
- Biochemistry
Background:
- Necroptosis is an inflammatory programmed cell death pathway.
- Mixed lineage kinase domain-like (MLKL) is the key executioner of necroptosis.
- Inositol phosphates (IPs) were previously implicated in MLKL activation.
Purpose of the Study:
- To elucidate the mechanism by which inositol phosphates activate MLKL.
- To identify the specific inositol phosphates and binding sites involved in MLKL activation.
- To investigate the role of inositol pentakisphosphate 2-kinase (IPPK) in necroptosis.
Main Methods:
- Biochemical assays to study the interaction between MLKL and inositol phosphates.
- Site-directed mutagenesis to identify critical residues in MLKL's auto-inhibitory region.
- Genetic deletion of IPPK in cells to assess its role in necroptosis.
Main Results:
- Specific inositol phosphates (I(1,3,4,6)P4, I(1,3,4,5,6)P5, and IP6) directly bind MLKL's N-terminal executioner domain (NED).
- Binding of these IPs destabilizes the auto-inhibitory region of MLKL, promoting its activation and membrane permeabilization.
- IP6 and IPPK are essential for necroptosis, as IPPK deletion abolishes IP6 production and inhibits cell death.
Conclusions:
- Inositol phosphates act as critical allosteric activators of MLKL.
- The interaction between specific IPs and MLKL's NED is a key regulatory step in necroptosis.
- This study reveals a novel mechanism for programmed cell death regulation involving IP metabolism.
Related Concept Videos
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Phosphate Buffer
Sodium dihydrogen phosphate does not fully dissociate in neutral or acidic solutions. When a strong base, such as sodium hydroxide (NaOH), is introduced into the solution, sodium dihydrogen phosphate...
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
Roles of Electrolytes: Calcium and Phosphate
The calcium concentration in blood plasma is primarily...
What is Natural Selection?
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...


